How Much Exercise Do You Actually Need Per Week?

Adults need 150 to 300 minutes of moderate-intensity aerobic activity per week, or 75 to 150 minutes of vigorous-intensity activity, plus muscle-strengthening work on two or more days a week (World Health Organization, 2020). Below that threshold still helps substantially: about 75 minutes a week is linked to 23% lower all-cause mortality.

The numbers, in one place

• 150–300 minutes of moderate-intensity aerobic activity per week for adults aged 18–64, or 75–150 minutes of vigorous-intensity activity, or an equivalent mix (WHO 2020 guidelines, published in British Journal of Sports Medicine).
• Two or more days a week of muscle-strengthening activity at moderate or greater intensity — a strong recommendation on moderate-certainty evidence (WHO, 2020).
• Half the minimum still buys most of the headline benefit: roughly 75 minutes a week of moderate activity was associated with 23% lower all-cause mortality (RR 0.77, 95% CI 0.73–0.80) compared with none (Garcia et al., BJSM, 2023).
• At the full 150 minutes: 31% lower all-cause mortality (RR 0.69, 95% CI 0.65–0.73); doubling again to 300 minutes moves it only to 34% (RR 0.66, 95% CI 0.62–0.70) (Garcia et al., BJSM, 2023).
• The plateau sits at roughly 3–5 times the minimum (HR 0.61, 95% CI 0.59–0.62), with no evidence of harm even at 10 times the minimum (HR 0.69, 95% CI 0.59–0.78) (Arem et al., JAMA Internal Medicine, 2015).
• Population scale: if every insufficiently active adult reached 150 minutes a week, an estimated 15.7% of premature deaths (95% CI 13.1–18.2) would have been averted (Garcia et al., BJSM, 2023).

What counts as moderate exercise?

Moderate-intensity physical activity is any activity performed at 3 to under 6 METs — three to six times the energy your body uses sitting at rest — which most people experience as about a 5 or 6 out of 10 on a perceived-exertion scale (WHO, 2020).

In practice that means brisk walking, cycling on flat ground, doubles tennis, mowing a lawn, or carrying groceries up a hill. The everyday test is conversational: you can talk in full sentences, but you would not comfortably sing.

Light activity — slow walking, bathing, incidental movement — sits between 1.5 and 3 METs and does not count toward the aerobic target under the WHO 2020 framework (WHO, 2020). It is not worthless, but it is not what the 150-minute figure was built on.

What counts as vigorous exercise, and why does it count double?

Vigorous-intensity physical activity is defined as 6.0 METs or more, typically a 7 or 8 out of 10 on a perceived-exertion scale (WHO, 2020). Running, swimming laps, fast cycling, singles tennis, and most interval training qualify.

Because it costs roughly twice the energy per minute, the guideline treats one minute of vigorous activity as equivalent to two minutes of moderate activity — hence 75–150 minutes rather than 150–300 (WHO, 2020). Mixed weeks are explicitly allowed: 30 minutes of running plus 90 minutes of brisk walking meets the minimum.

Whether the intensity itself matters beyond the energy total is less settled. A 30-year analysis of 116,221 US adults in the Nurses’ Health Study and Health Professionals Follow-up Study (Lee et al., Circulation, 2022) found meeting the vigorous guideline was associated with a hazard ratio of 0.81 (95% CI 0.76–0.87) for all-cause mortality, while meeting the moderate guideline gave a similar 19–25% reduction.

Is less than 150 minutes still worth it?

Yes — and this is the single most useful finding in the whole literature. The steepest part of the dose-response curve is the move from doing nothing to doing something, not the move from adequate to impressive.

The largest harmonised analysis to date pooled 196 articles covering 94 cohorts and more than 30 million participants, with 811,616 deaths across 163 million person-years of follow-up (Garcia et al., British Journal of Sports Medicine, 2023). At half the recommended minimum — about 75 minutes of moderate activity a week — all-cause mortality risk was 23% lower than at zero (RR 0.77, 95% CI 0.73–0.80).

Put differently: the first 75 minutes a week delivered roughly three-quarters of the mortality benefit seen at the full 150 minutes. The authors concluded that inverse non-linear associations suggest substantial protection from small increases in activity among inactive adults.

The pooled analysis of 661,137 adults in the National Cancer Institute Cohort Consortium found the same shape: people doing less than the recommended minimum still had 20% lower mortality than the completely inactive (HR 0.80, 95% CI 0.78–0.82) (Arem et al., JAMA Internal Medicine, 2015).

How much does the risk drop at each activity level?

The table below maps weekly volume against observed all-cause mortality risk relative to doing nothing. Rows from Arem et al. were reported as multiples of a 7.5 MET-hour-per-week minimum and are converted here to approximate moderate-intensity minutes.

Activity level	Approx. moderate-intensity minutes/week	All-cause mortality vs no activity	Source
None	0	Reference (1.00)	—
Half the guideline minimum	~75	23% lower (RR 0.77, 95% CI 0.73–0.80)	Garcia et al., BJSM, 2023
Below the minimum (any amount)	<150	20% lower (HR 0.80, 95% CI 0.78–0.82)	Arem et al., JAMA Intern Med, 2015
Guideline minimum	150	31% lower (RR 0.69, 95% CI 0.65–0.73)	Garcia et al., BJSM, 2023
Top of the guideline range	300	34% lower (RR 0.66, 95% CI 0.62–0.70)	Garcia et al., BJSM, 2023
2–3× the minimum	~300–450	37% lower (HR 0.63, 95% CI 0.62–0.65)	Arem et al., JAMA Intern Med, 2015
3–5× the minimum (observed plateau)	~450–750	39% lower (HR 0.61, 95% CI 0.59–0.62)	Arem et al., JAMA Intern Med, 2015
10× the minimum or more	~1,500+	31% lower (HR 0.69, 95% CI 0.59–0.78) — no evidence of harm	Arem et al., JAMA Intern Med, 2015

What about the muscle-strengthening part everyone forgets?

The WHO 2020 guidelines recommend muscle-strengthening activity at moderate or greater intensity involving all major muscle groups on two or more days a week — a strong recommendation supported by moderate-certainty evidence (Bull et al., BJSM, 2020). It is a separate target, not a substitute for the aerobic minutes.

A systematic review and meta-analysis of 16 prospective cohort studies found muscle-strengthening activity associated with a 10–17% lower risk of all-cause mortality, cardiovascular disease, total cancer, diabetes and lung cancer, independent of aerobic activity (Momma et al., British Journal of Sports Medicine, 2022).

The volume needed is smaller than most people assume. That same analysis found J-shaped curves with maximum risk reduction of roughly 10–20% at approximately 30–60 minutes per week of strength work for all-cause mortality, cardiovascular disease and total cancer — with diabetes showing an L-shaped curve and a large reduction up to 60 minutes a week.

Beyond that, the evidence thins fast. The WHO guideline development group stated plainly that there was no evidence to support a dose-response association with higher volumes of muscle-strengthening activity (Bull et al., BJSM, 2020).

Where do the returns flatten out?

In the harmonised meta-analysis of 94 cohorts, differences in risk were largest between 0 and 8.75 marginal MET-hours per week — the equivalent of the recommended 150 minutes — with smaller marginal differences up to 17.5 MET-hours (roughly 300 minutes), beyond which additional differences were small and uncertain (Garcia et al., BJSM, 2023).

The NCI pooled analysis put the benefit threshold at 3 to 5 times the recommended minimum (HR 0.61, 95% CI 0.59–0.62), but framed the increment honestly: compared with simply meeting the minimum, the extra benefit was modest — 31% versus 39% risk reduction (Arem et al., JAMA Internal Medicine, 2015).

The 30-year Nurses’ Health Study and Health Professionals Follow-up Study analysis reached a compatible conclusion: near-maximum association with lower mortality was achieved at roughly 150–300 minutes of vigorous activity or 300–600 minutes of moderate activity per week (Lee et al., Circulation, 2022).

Note what that implies. The optimum in these datasets sits above the guideline minimum, but the gap between “meeting the guideline” and “optimal” is far smaller than the gap between “nothing” and “meeting the guideline”.

Can you exercise too much?

For all-cause mortality, the large cohort data show no reversal. Arem and colleagues specifically looked for it and found no excess risk at 10 or more times the recommended minimum (HR 0.69, 95% CI 0.59–0.78), concluding that clinicians need not discourage adults already at high activity levels (JAMA Internal Medicine, 2015).

The Circulation analysis agreed: levels above 300 minutes a week of vigorous or 600 minutes of moderate activity showed neither further reduction nor harm (Lee et al., 2022).

But confidence intervals widen dramatically at the top end — Arem’s 10-times-minimum estimate spans 0.59 to 0.78, versus 0.59 to 0.62 at the plateau — because very few people in these cohorts train that much. “No evidence of harm” at extreme volumes is a statement about statistical power as much as about physiology.

What this evidence does not establish

Every mortality figure above comes from observational cohorts, not randomised trials. Nobody has randomised hundreds of thousands of adults to decades of different exercise doses, and nobody will. These are associations.

• Self-reported activity. The Garcia team noted that their exposure estimates come from a variety of self-reported questionnaires capturing mostly moderate and vigorous activity, many without validation or calibration data, and that assumptions about intensity and duration had to be made during harmonisation (BJSM, 2023). Device-based measurement gives different numbers.
• Reverse causation. Early illness reduces activity before it causes death, which inflates the apparent benefit of exercise. Good studies exclude early follow-up deaths to mitigate this, but they cannot eliminate it.
• Residual confounding. People who exercise also tend to smoke less, sleep better, eat differently and have more money and time. Statistical adjustment reduces this but never removes it.
• Sparse data at the extremes. Garcia and colleagues explicitly noted that very high activity levels are not reported in many original studies, leaving substantial uncertainty at those levels.
• No sedentary threshold. The WHO group recommended reducing sedentary time but stated that evidence was insufficient to quantify a threshold (Bull et al., 2020). There is no validated “maximum hours of sitting” number.

On funding and conflicts: the WHO 2020 guideline development was financially supported by the Public Health Agency of Canada and the Government of Norway, with competing interests declared as none (Bull et al., BJSM, 2020). Garcia et al. (2023) and Momma et al. (2022) also declared no competing interests; Garcia et al. was supported by UK Medical Research Council and European Research Council grants. The Arem et al. (2015) pooled analysis was supported by the US National Cancer Institute Intramural Research Program and the American Cancer Society.

How should you actually use these numbers?

If you currently do nothing, the highest-value target is not 150 minutes — it is the first 20 minutes. The curve is steepest at the bottom, and roughly 75 minutes a week already captures most of the mortality association observed at the full guideline dose (Garcia et al., BJSM, 2023).

If you already meet the aerobic guideline but skip strength work, that is the obvious gap. Two sessions a week totalling 30–60 minutes lines up with where the muscle-strengthening benefit peaked in the pooled cohort data (Momma et al., BJSM, 2022).

If you already train five or more hours a week, the mortality data offer neither a reason to add more nor a reason to cut back. Above the plateau, the curve is flat and the confidence intervals are wide.

This article is written by a research and content lead, not a clinician, and is educational rather than medical advice. Anyone with cardiovascular disease, a musculoskeletal injury, or a long period of inactivity behind them should talk to a qualified clinician before making a large jump in training volume.

Sources

• Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451-1462. PubMed
• Garcia L, Pearce M, Abbas A, et al. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies. Br J Sports Med. 2023;57(15):979-989. PubMed
• Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175(6):959-967. PubMed
• Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med. 2022;56(13):755-763. PubMed
• Lee DH, Rezende LFM, Joh HK, et al. Long-term leisure-time physical activity intensity and all-cause and cause-specific mortality: a prospective cohort of US adults. Circulation. 2022;146(7):523-534. PubMed